Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)

Open Posted

Opportunity number
RFA-MH-27-150
Agency
Applications due
Award size
Not on record

Opportunity facts

Funding instrument
Cooperative Agreement
Category
  • Health
Eligible applicants
  • For Profit Organizations
  • 501(c)(3) Nonprofits
  • City/Township Governments
  • County Governments
  • Non-501(c)(3) Nonprofits
  • Special District Governments
  • Public or Indian Housing Auth.
  • Higher Education Inst. (Private)
  • Tribal Organizations (Not Federally Recognized)
  • Small Businesses
  • State Governments
  • Higher Education Inst. (Public)
  • Tribal Governments (Federally Recognized)
  • Other
  • Independent School Districts
Points of contact

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Institute of Mental Health (NIMH) within NIH is soliciting applications under RFA-MH-27-150 for a UM1 cooperative agreement establishing a Rapid-Acting Psychotropic Interventional Drugs Clinical Trials Network (RAPIDs-CTN), with applications due June 10, 2027. The opportunity was forecast on September 16, 2026, and the full announcement posted November 12, 2026 supersedes that forecast. The program is intended only for large-scale, coordinated network projects that could not be achieved through other, more standard grant mechanisms.

Eligible applicants include for-profit organizations, 501(c)(3) and non-501(c)(3) nonprofits, small businesses, public and private higher education institutions, state, county, city/township, and special district governments, public housing authorities, independent school districts, federally recognized and non-federally recognized tribal organizations, and faith-based or community-based organizations. Other listed categories include eligible federal agencies, U.S. territories or possessions, and regional organizations.

NIMH intends to commit up to $10 million to fund at least one award in FY27 and FY28, and the National Institute on Drug Abuse intends to commit up to $2 million for one award in FY27. The project period is a maximum of five years: Stage 1 (Years 1-2) covers network establishment and pilot studies, and Stage 2 (Years 3-5) covers full-scale pragmatic trial execution. The earliest project start date is January 5, 2027.

Required infrastructure includes a Data Coordinating Center, federated clinical sites across inpatient, emergency department, VA healthcare, and community mental health center settings, unified pragmatic trial protocols, NIMH Common Data Elements, biostatistical leadership, electronic data capture, and automated data validation. Applications must include letters of collaboration from clinical sites and detailed milestone plans with quantifiable annual metrics. Required effort is at least 2.4 person-months (20%) annually for the Contact PD/PI and the DCC Director, at least 1.8 person-months (15%) for Multi-PD/PIs, and at least 1.2 person-months (10%) for Clinical Site Lead Investigators.

Applications receive scientific merit review by peer review panels, followed by approval from the National Advisory Mental Health Council. The source does not assign weights to review criteria. The NOFO file cites Assistance Listing 93.24R (Mental Health Research - Research Projects) and 93.DA1 (Drug Use and Addiction Research Programs - Research Projects), and the opportunity is also assigned to 93.242 (Mental Health Research Grants). No incumbent recipient is named.

Synopsis

This notice of funding opportunity (NOFO) encourages applications to establish a Rapid-Acting Psychotropic Interventional Drugs - Clinical Trials Network (RAPIDs-CTN). The overarching purpose is to generate actionable, real-world evidence to guide the safe and effective implementation of RAPIDs in routine clinical practice, answering urgent questions about how these treatments can be delivered sustainably outside tightly controlled experimental settings. This NOFO utilizes a milestone-driven UM1 Cooperative Agreement mechanism structured into two operational stages: Stage 1 (Years 1-2) for network establishment and pilot studies, and Stage 2 (Years 3-5) focuses for full-scale execution of proposed pragmatic trials. This program is intended only for large-scale, coordinated network projects that could not be achieved using other, more standard grant mechanisms.

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;

Files

File Type Posted
PKG00294561.pdf PDF
RFA-MH-27-150-Full-Announcement.html HTML file

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity